Drug Trend: Bold Steps to Standout Results, Part 2
As the #1 driver of drug trend, inflammatory conditions account for 47% of all specialty pharmacy spend and 23% of overall spend. Managing this ever-growing category takes consistent effort and an arsenal of tools. In part 2 of our trend podcast, WellDyne clinical leaders Nick Page and Patty Taddei-Allen focus on inflammatory conditions to reveal how a consistent, thoughtful approach produces results. This is your opportunity to gain insight into dosing escalations, testing, diagnostics, biosimilars, and emerging opportunities and challenges in this high-cost area. Join us for podcast episodes that reveal ideas for maximizing change and opportunity in today’s volatile pharmacy industry – and be sure to listen to Drug Trend: Bold Steps to Standout Results, Part 1.
